Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Aciclovir sodium equivalent to 25 mg/mL aciclovir Injection, solution Pharmacia & Upjohn (Perth) Pty Limited, Bentley, Western Australia, Australia Aciclovir Lamivudine 150 mg, zidovudine 300 mg Tablet, film coated Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom and Glaxo Wellcome Australia Limited, Boronia, Victoria, Australia Combivir Indinavir sulphate 250 mg, 500 mg equivalent to 200 mg, 400 mg indinavir Capsules Merck & Co Inc., Elkton, Virginia, United States of America Crixivan Rizatriptan benzoate 7.265 mg, 14.53 mg equivalent to 5 mg, 10 mg rizatriptan Tablets, film coated Merck Sharp & Dohme Limited, Cramlington, Northumberland, England and Merck Sharp and Dohme, South Granville, New South Wales, Australia Maxalt Rizatriptan benzoate 7.265 mg, 14.53 mg equivalent to 5 mg, 10 mg rizatriptan Wafers Scherer DDS Limited, Blagrove, Swindon, Wiltshire, England Maxalt Triamcinolone acetonide 55 g/dose Spray, nasal suspension Rhone-Poulenc Rorer Puerto Rico Inc., Manati, Puerto Rico Nasacort AQ Adsorbed tetanus vaccine 40IU, diptheria toxoid (adsorbed) 30IU, pertussis 69kDa outer membrane protein (pertactin) 3g, pertussis filamentous haemagglutinin 5g, pertussis fimbriae (2+3) 5g, pertussis toxoid (adsorbed) 10g per 0.5 mL dose Injection, suspension Connaught Laboratories Limited, Toronto, Ontario, Canada Tripacel Abacavir sulphate 23.4 mg/mL equivalent to 20 mg/mL abacavir base Solution, oral Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom Ziagen Abacavir sulphate 351 mg equivalent to 300 mg abacavir Tablet, film coated Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom Ziagen Dated this 16th day of February 1999. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.